Long-Term Mortality of Tuberculosis Survivors in Korea: A Population-based Longitudinal Study
暂无分享,去创建一个
J. Sohn | K. Han | Jin-Hyung Jung | Hyung Koo Kang | Hayoung Choi | S. Park | Sang Hyuk Kim | D. Shin | Hyun Lee
[1] K. Han,et al. Association between Smoking Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study , 2022, Journal of personalized medicine.
[2] B. Cho,et al. National General Health Screening Program in Korea: history, current status, and future direction: A scoping review , 2022, Precision and Future Medicine.
[3] J. Sohn,et al. Female reproductive factors and incidence of non-tuberculous mycobacterial pulmonary disease among postmenopausal women in Korea. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] S. Rhee,et al. Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study , 2021, Frontiers in Nutrition.
[5] Hojoong Kim,et al. Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. , 2021, Annals of the American Thoracic Society.
[6] N. Arinaminpathy,et al. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis , 2021, The Lancet Global Health.
[7] Hayoung Choi. Nosocomial exposure to tuberculosis: a snapshot of South Korea , 2021, The Korean journal of internal medicine.
[8] S. Swaminathan,et al. Long term Survival of Treated Tuberculosis patients in comparison to General Population in South India - a Matched Cohort study. , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[9] Y. Park,et al. Changes in Nutritional Status in Pulmonary Tuberculosis: Longitudinal Changes in BMI According to Acid-Fast Bacilli Smear Positivity , 2020, Journal of clinical medicine.
[10] L. Bastos,et al. Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis , 2020, PloS one.
[11] Y. Kang,et al. Long-term mortality of patients with tuberculosis in Korea. , 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[12] D. Visca,et al. Rehabilitation, optimized nutritional care and boosting host internal milieu to improve long-term treatment outcomes in TB patients. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[13] H. Park,et al. Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study , 2020, Respirology.
[14] C. Carvalho,et al. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study , 2020, The Lancet. Infectious diseases.
[15] J. Johnston,et al. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. , 2019, The Lancet. Infectious diseases.
[16] A. Welte,et al. Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: A pilot study. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[17] V. H. Nguyen,et al. Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Y. Zheng,et al. Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] R. Chaisson,et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] A. Leventhal,et al. Mortality after anti-tuberculosis treatment completion: results of long-term follow-up. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[21] E. Guallar,et al. Korean National Health Insurance Database. , 2016, JAMA internal medicine.
[22] T. Sterling,et al. Tuberculosis and cardiovascular disease: linking the epidemics , 2015, Tropical Diseases, Travel Medicine and Vaccines.
[23] Fernando A. Wilson,et al. Mortality hazard and survival after tuberculosis treatment. , 2015, American journal of public health.
[24] F. Kok,et al. Survival and associated mortality risk factors among post-treatment pulmonary tubercolosis patients in the northwest of China. , 2015, European review for medical and pharmacological sciences.
[25] Å. Andersen,et al. Long-term mortality in patients with pulmonary and extrapulmonary tuberculosis: a Danish nationwide cohort study , 2014, Clinical epidemiology.
[26] S. Jang,et al. The association between airflow obstruction and radiologic change by tuberculosis. , 2014, Journal of thoracic disease.
[27] F. Sung,et al. Tuberculosis increases the subsequent risk of acute coronary syndrome: a nationwide population-based cohort study. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[28] M. Rahu,et al. Overall and cause-specific mortality among patients with tuberculosis and multidrug-resistant tuberculosis. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[29] J. Yim,et al. Use of inhaled corticosteroids and the risk of tuberculosis , 2013, Thorax.
[30] Z. Memish,et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. , 2013, The Lancet. Infectious diseases.
[31] M. Petticrew,et al. The social determinants of tuberculosis: from evidence to action. , 2011, American journal of public health.
[32] S. Anton,et al. How Much Walking Is Needed To Improve Cardiorespiratory Fitness? An Examination of the 2008 Physical Activity Guidelines for Americans , 2011, Research quarterly for exercise and sport.
[33] A. Bernabé-Ortiz,et al. Weight Variation over Time and Its Association with Tuberculosis Treatment Outcome: A Longitudinal Analysis , 2011, PloS one.
[34] C. Dye,et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. , 2010, International journal of epidemiology.
[35] R. Perera,et al. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases , 2010, BMC family practice.
[36] Jiachun Lu,et al. COPD in Chinese nonsmokers , 2009, European Respiratory Journal.
[37] P. R. Narayanan,et al. Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[38] G. Valdivia,et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America , 2007, European Respiratory Journal.
[39] R. Adegbola,et al. Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. , 2005, International journal of epidemiology.
[40] N. Beeching,et al. Elevated mortality following diagnosis with a treatable disease: tuberculosis. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[41] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.